ADHD biotech Neos Therapeutics files for a $69 million IPO - (NASDAQ via NewsPoints Desk)

  • Neos Therapeutics unveiled terms to raise up to $69 million in an initial public offering (IPO), as reported NASDAQ.
  • The biotech firm did not divulge the terms of the IPO.

To read more NewsPoints articles, click here.